Cancer vaccine: Difference between revisions
CSV import |
No edit summary |
||
| Line 30: | Line 30: | ||
{{Vaccine-stub}} | {{Vaccine-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 16:50, 22 March 2025
Cancer Vaccine
A cancer vaccine is a type of vaccine that either treats existing cancer or prevents development of a cancer. Cancer vaccines belong to a class of substances known as biological response modifier. These modifiers work by stimulating or restoring the immune system’s ability to fight infections and disease.
Types of Cancer Vaccines[edit]
There are two broad types of cancer vaccines: preventive (or prophylactic) vaccines and treatment (or therapeutic) vaccines.
Preventive Cancer Vaccines[edit]
Preventive cancer vaccines are intended to prevent cancer from developing in healthy people. These vaccines work by preventing viral infections that can lead to certain types of cancer. Examples include the human papillomavirus (HPV) vaccine and the hepatitis B vaccine, which can prevent certain types of cervical, anal, and liver cancers, respectively.
Treatment Cancer Vaccines[edit]
Treatment cancer vaccines, also known as therapeutic vaccines, are a form of immunotherapy. They are used to treat existing cancers by strengthening the body's natural defenses against the cancer. The Sipuleucel-T (Provenge) vaccine, used to treat prostate cancer, is an example of a treatment cancer vaccine.
Development and Approval[edit]
The development and approval of cancer vaccines involves a rigorous process overseen by regulatory bodies such as the Food and Drug Administration (FDA) in the United States. This process includes preclinical testing in laboratories, followed by clinical trials in humans. Once a vaccine has demonstrated safety and efficacy, it can be approved for use in the general population.
Challenges and Future Directions[edit]
Despite the promise of cancer vaccines, there are several challenges to their widespread use. These include the complexity of the immune response, the difficulty in identifying appropriate antigen targets, and the need for personalized treatment strategies. However, ongoing research and technological advancements hold promise for the future development of effective cancer vaccines.
